It is vital to have evidence-informed clinical practice guidelines or clinical indications to guide the usage of high-cost drugs in the benefits package under the Indonesian universal health coverage (JKN), managed by BPJS Kesehatan. A transparent and legit mechanism is required to support and mo

Colorectal cancer is the third most common cancer in Indonesia with approximately 28,000 patients diagnosed each year. Without population-based screening, patients are often treated when they reach the advanced stage. Bevacizumab, a newly available high-cost treatment for metastatic colorectal ca

“United we stand, divided we fall” is a Thai idiom used to exemplify the importance of staying united and of teamwork and common interests. This idiom is reaffirmed in the context of the COVID-19 pandemic, shown in the global nature of catastrophe and the shared prospects of recovery. However, p

Health equity is a major concern worldwide, spanning regions and income levels. Countries recognize the importance of addressing health disparities to ensure fair access to healthcare. Health Inequality Aversion Surveys provide insights into how different nations perceive health inequality. These

Chayapat Rachatan is currently a Project Associate at HITAP. She supports the HTA and health system research. Her research studies focus on COVID-19 policy research and decision support, effectiveness evaluation of COVID-19 vaccine chatbot, cost analysis of governance system in health sector, situational analysis of infectious disease modelling in

The policy \\\\\\\" One ID card smart hospital\\\\\\\" is a government policy from the Ministry of Public Health\\\\\\\'s Strategic Plan for Digital Health in 2024, addressing point 10 regarding digital health. Its objective is to elevate healthcare services by establishing data linkage across all levels and affiliations of public healthcare units.

Thailand’s dialysis policy reform, introduced in 2022, aimed to enable universal access to life-sustaining dialysis, but instead exposed systemic vulnerabilities that undermined dialysis quality, compromised patient safety and threatened sustainability of care. These outcomes highlight three ethical

Abstract Surrogate endpoints are frequently used as primary outcomes in clinical trials. This is appropriate when they are validated for their ability to predict clinical benefit measured on patient-relevant target outcome(s). Such validation is often lacking, thus increasing uncertainty in the dec

ในยุคที่ประชากรสูงอายุเพิ่มขึ้น พร้อมกับผู้ป่วยโรคเรื้อรัง ระบบสุขภาพของหลายประเทศ รวมถึงประเทศไทย กำลังเผชิญกับภาระค่าใช้จ่ายที่เพิ่มขึ้นอย่างต่อเนื่อง แต่รู้หรือไม่ว่าคนเพียง 5% ที่เรียกว่า "ผู้ใช้บริการที่มีค่าใช้จ่ายสูง" (High-Cost Users: HCUs) กลับใช้ทรัพยากรไปมากถึงเกือบครึ่งของงบประมาณสุขภาพท